The global veterinary active pharmaceutical ingredients manufacturing market is expected to reach USD 13.47 billion by 2030, registering a CAGR of 6.8% from 2024 to 2030. The key factors driving market growth include rising animal population & pet humanization, high pet expenditure, initiatives by key market players, outsourcing of manufacturing functions to third parties, and a high prevalence of diseases in animals. Suanfarma, for instance, is involved in the veterinary manufacturing of a wide range of APIs across therapeutic categories, target species, and synthesis types. The company manufactures two proprietary APIs, namely, Tiamulin and Tetracycline HCl. ![Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market]( "Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market")
Outsourcing the manufacturing function to third parties is a significant driver of the market growth. This enables pharmaceutical companies to concentrate on their core competencies, such as R&D, regulatory affairs, and marketing. This strategic focus on core functions enhances overall operational efficiency and accelerates the development and commercialization of new veterinary APIs. Outsourcing to CMOs with expertise in animal health allows pharmaceutical companies to tap into the specialized skills of experienced professionals. This can improve product quality, compliance with regulatory standards, and enhanced manufacturing processes. Contract manufacturers with efficient processes can expedite the production timeline, allowing companies to launch their products more quickly and respond promptly to emerging market needs.
Initiatives by regulatory agencies and animal health organizations are also expected to drive market growth. For instance, in September 2023, the U.S. FDA released an agenda to promote innovation in animal biotech and veterinary products as part of the Animal and Veterinary Innovation Agenda. Thesesteps are intended to modernize the agency’s approach to evaluating and supporting the development of innovative veterinary products thereby increasing regulatory efficiency, flexibility, and predictability. An increase in the number of government initiatives, that help promote animal health, is also expected to fuel the overall market growth. The launch of One Health Initiative for enhancing animal healthcare standards has improved growth prospects for the industry. This joint project unified clinical care, disease surveillance, and education & research areas for better control of diseases.
This product will be delivered within 2 business days.
Outsourcing the manufacturing function to third parties is a significant driver of the market growth. This enables pharmaceutical companies to concentrate on their core competencies, such as R&D, regulatory affairs, and marketing. This strategic focus on core functions enhances overall operational efficiency and accelerates the development and commercialization of new veterinary APIs. Outsourcing to CMOs with expertise in animal health allows pharmaceutical companies to tap into the specialized skills of experienced professionals. This can improve product quality, compliance with regulatory standards, and enhanced manufacturing processes. Contract manufacturers with efficient processes can expedite the production timeline, allowing companies to launch their products more quickly and respond promptly to emerging market needs.
Initiatives by regulatory agencies and animal health organizations are also expected to drive market growth. For instance, in September 2023, the U.S. FDA released an agenda to promote innovation in animal biotech and veterinary products as part of the Animal and Veterinary Innovation Agenda. Thesesteps are intended to modernize the agency’s approach to evaluating and supporting the development of innovative veterinary products thereby increasing regulatory efficiency, flexibility, and predictability. An increase in the number of government initiatives, that help promote animal health, is also expected to fuel the overall market growth. The launch of One Health Initiative for enhancing animal healthcare standards has improved growth prospects for the industry. This joint project unified clinical care, disease surveillance, and education & research areas for better control of diseases.
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights
- The chemical-based API segment dominated the market with a share of 71.3% in 2023. The biological API segment is anticipated to grow at the fastest CAGR of 8.3% from 2024 to 2030
- The production animals segment held the largest revenue share in 2023. The companion animals segment is projected to grow at the fastest growth rate from 2024 to 2030
- The in-house service type segment accounted for the highest revenue share in 2023. The contract outsourcing segment is projected to grow the fastest CAGR over the forecast years
- The anti-infectives segment held the highest share in 2023. The other therapeutic category segment includes oncology, diabetes, and other drugs
- North America was the leading regional market in 2023 and held the largest revenue share of 37.8% in the same year. Asia-Pacific, on the other hand, is anticipated to register the fastest CAGR of 7.9% from 2024 to 2030
- The growing need for veterinary drugs & pharmaceuticals due to the high prevalence of animal diseases and an increasing focus on pet healthcare drive the demand for veterinary APIs
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing uptake of CDMO services
3.2.1.2. Increasing advancements in veterinary medicine
3.2.1.3. Increasing prevalence of diseases in animals
3.2.1.4. Increasing animal health expenditure
3.2.2. Market Restraints Analysis
3.2.2.1. Complex regulations
3.2.2.2. Limited Awareness and Education
3.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
3.4. Estimated Animal Population, by Key Species & Key Countries, 2023
3.5. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing uptake of CDMO services
3.2.1.2. Increasing advancements in veterinary medicine
3.2.1.3. Increasing prevalence of diseases in animals
3.2.1.4. Increasing animal health expenditure
3.2.2. Market Restraints Analysis
3.2.2.1. Complex regulations
3.2.2.2. Limited Awareness and Education
3.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
3.4. Estimated Animal Population, by Key Species & Key Countries, 2023
3.5. COVID-19 Impact Analysis
Chapter 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Service Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary active pharmaceutical ingredients manufacturing market: service type movement analysis, 2023 & 2030 (USD Million)
4.3. In House
4.3.1. In house market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4. Contract Outsourcing
4.4.1. Contract outsourcing market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2. Contract Development
4.4.2.1. Contract development market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2.2. Preclinical Development
4.4.2.2.1. Preclinical development market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2.3. Clinical Development
4.4.2.3.1. Clinical development market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.3. Contract Manufacturing
4.4.3.1. Contract manufacturing market revenue estimates and forecasts, 2018-2030 (USD Million)
4.2. Veterinary active pharmaceutical ingredients manufacturing market: service type movement analysis, 2023 & 2030 (USD Million)
4.3. In House
4.3.1. In house market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4. Contract Outsourcing
4.4.1. Contract outsourcing market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2. Contract Development
4.4.2.1. Contract development market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2.2. Preclinical Development
4.4.2.2.1. Preclinical development market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2.3. Clinical Development
4.4.2.3.1. Clinical development market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.3. Contract Manufacturing
4.4.3.1. Contract manufacturing market revenue estimates and forecasts, 2018-2030 (USD Million)
Chapter 5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Synthesis Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement analysis, 2023 & 2030 (USD Million)
5.3. Chemical-based API
5.3.1. Chemical-based API market revenue estimates and forecasts, 2018-2030 (USD Million)
5.4. Biological API
5.4.1. Biological API market revenue estimates and forecasts, 2018-2030 (USD Million)
5.5. HPAPI
5.5.1. HPAPI market revenue estimates and forecasts, 2018-2030 (USD Million)
5.2. Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement analysis, 2023 & 2030 (USD Million)
5.3. Chemical-based API
5.3.1. Chemical-based API market revenue estimates and forecasts, 2018-2030 (USD Million)
5.4. Biological API
5.4.1. Biological API market revenue estimates and forecasts, 2018-2030 (USD Million)
5.5. HPAPI
5.5.1. HPAPI market revenue estimates and forecasts, 2018-2030 (USD Million)
Chapter 6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Animal Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary active pharmaceutical ingredients manufacturing market: animal type movement analysis, 2023 & 2030 (USD Million)
6.3. Production Animals
6.3.1. Production animals market revenue estimates and forecasts, 2018-2030 (USD Million)
6.4. Companion Animals
6.4.1. Companion animals market revenue estimates and forecasts, 2018-2030 (USD Million)
6.2. Veterinary active pharmaceutical ingredients manufacturing market: animal type movement analysis, 2023 & 2030 (USD Million)
6.3. Production Animals
6.3.1. Production animals market revenue estimates and forecasts, 2018-2030 (USD Million)
6.4. Companion Animals
6.4.1. Companion animals market revenue estimates and forecasts, 2018-2030 (USD Million)
Chapter 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Therapeutic Category Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Veterinary active pharmaceutical ingredients manufacturing market: therapeutic category movement analysis, 2023 & 2030 (USD Million)
7.3. Antiparasitics
7.3.1. Antiparasitics market revenue estimates and forecasts, 2018-2030 (USD Million)
7.4. Anti-infectives
7.4.1. Anti-infectives market revenue estimates and forecasts, 2018-2030 (USD Million)
7.5. NSAIDs
7.5.1. NSAIDs market revenue estimates and forecasts, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.2. Veterinary active pharmaceutical ingredients manufacturing market: therapeutic category movement analysis, 2023 & 2030 (USD Million)
7.3. Antiparasitics
7.3.1. Antiparasitics market revenue estimates and forecasts, 2018-2030 (USD Million)
7.4. Anti-infectives
7.4.1. Anti-infectives market revenue estimates and forecasts, 2018-2030 (USD Million)
7.5. NSAIDs
7.5.1. NSAIDs market revenue estimates and forecasts, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Regional Estimates & Trend Analysis
8.1. Veterinary active pharmaceutical ingredients manufacturing market share, by region, 2023 & 2030, (USD Million)
8.2. Regional Outlook
8.3. North America
8.3.1. North America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. U.S. veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Canada veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4. Europe
8.4.1. Europe veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. UK veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Germany veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. France veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Italy veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Spain veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key Country Dynamics
8.4.7.2. Sweden veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key Country Dynamics
8.4.8.2. Denmark veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Norway veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5. Asia-Pacific
8.5.1. Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.2. China
8.5.2.1. Key Country Dynamics
8.5.2.2. China veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.3. Japan
8.5.3.1. Key Country Dynamics
8.5.3.2. Japan veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. India veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key Country Dynamics
8.5.5.2. South Korea veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.6. Australia
8.5.6.1. Key Country Dynamics
8.5.6.2. Australia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.7. Thailand
8.5.7.1. Key Country Dynamics
8.5.7.2. Thailand veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6. Latin America
8.6.1. Latin America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Brazil veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6.3. Mexico
8.6.3.1. Key Country Dynamics
8.6.3.2. Mexico veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6.4. Argentina
8.6.4.1. Key Country Dynamics
8.6.4.2. Argentina veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7. Middle East and Africa
8.7.1. Middle East and Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key Country Dynamics
8.7.2.2. Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key Country Dynamics
8.7.3.2. UAE veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.4. South Africa
8.7.4.1. Key Country Dynamics
8.7.4.2. South Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Kuwait veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.2. Regional Outlook
8.3. North America
8.3.1. North America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. U.S. veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Canada veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4. Europe
8.4.1. Europe veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. UK veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Germany veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. France veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Italy veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Spain veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key Country Dynamics
8.4.7.2. Sweden veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key Country Dynamics
8.4.8.2. Denmark veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Norway veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5. Asia-Pacific
8.5.1. Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.2. China
8.5.2.1. Key Country Dynamics
8.5.2.2. China veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.3. Japan
8.5.3.1. Key Country Dynamics
8.5.3.2. Japan veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. India veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key Country Dynamics
8.5.5.2. South Korea veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.6. Australia
8.5.6.1. Key Country Dynamics
8.5.6.2. Australia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.5.7. Thailand
8.5.7.1. Key Country Dynamics
8.5.7.2. Thailand veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6. Latin America
8.6.1. Latin America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Brazil veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6.3. Mexico
8.6.3.1. Key Country Dynamics
8.6.3.2. Mexico veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.6.4. Argentina
8.6.4.1. Key Country Dynamics
8.6.4.2. Argentina veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7. Middle East and Africa
8.7.1. Middle East and Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key Country Dynamics
8.7.2.2. Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key Country Dynamics
8.7.3.2. UAE veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.4. South Africa
8.7.4.1. Key Country Dynamics
8.7.4.2. South Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Kuwait veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Zoetis
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Alivira Animal Health Limited
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Ofichem Group
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Chempro Pharma Private Limited
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Siflon Drugs
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Qilu Animal Health Products Co., Ltd.
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Vetpharma
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. SUANFARMA
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. MENADIONA
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Excel Industries Ltd.
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Others
9.5. List of Other Key Market Players
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Zoetis
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Alivira Animal Health Limited
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Ofichem Group
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Chempro Pharma Private Limited
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Siflon Drugs
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Qilu Animal Health Products Co., Ltd.
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Vetpharma
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. SUANFARMA
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. MENADIONA
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Excel Industries Ltd.
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Others
9.5. List of Other Key Market Players
List of Tables
Table 1 List of secondary sources
Table 2 Global veterinary active pharmaceutical ingredients manufacturing market, by region, 2018-2030 (USD Million)
Table 3 Global veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 4 Global veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 -2030 (USD Million)
Table 5 Global veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 6 Global veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 7 Global veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 8 Global veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 9 North America veterinary active pharmaceutical ingredients manufacturing market, by country, (USD Million) 2018-2030 (USD Million)
Table 10 North America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 11 North America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 12 North America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 13 North America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 14 North America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 15 North America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 16 U.S. veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 17 U.S. veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 18 U.S. veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 19 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 20 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 21 U.S. veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 22 Canada veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 23 Canada veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018-2030 (USD Million)
Table 24 Canada veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
Table 25 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, (USD Million) 2018-2030 (USD Million)
Table 26 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract development, (USD Million) 2018-2030 (USD Million)
Table 27 Canada veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018-2030 (USD Million)
Table 28 Europe veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 29 Europe veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 30 Europe veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 31 Europe veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 32 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 33 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 34 Europe veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 35 Germany veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 36 Germany veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 37 Germany veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 38 Germany veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 39 Germany veterinary active pharmaceutical ingredients manufacturing , by contract development, 2018-2030 (USD Million)
Table 40 Germany veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 41 UK veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 42 UK veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018- 2030 (USD Million)
Table 43 UK veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 44 UK veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 45 UK veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 46 UK veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 47 France veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 48 France veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 49 France veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 50 France veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 51 France veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 52 France veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 53 Italy veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 54 Italy veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 55 Italy veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 56 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 57 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 58 Italy veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 59 Spain veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 60 Spain veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 61 Spain veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 62 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 63 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 64 Spain veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 65 Denmark veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 66 Denmark veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 67 Denmark veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 68 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 69 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 70 Denmark veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 71 Sweden veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 72 Sweden veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 73 Sweden veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 74 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 75 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 76 Sweden veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 77 Norway veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 78 Norway veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 79 Norway veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 80 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 81 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 82 Norway veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 83 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 84 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 85 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 86 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 87 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 88 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 89 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 90 China veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 91 China veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 92 China veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 93 China veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 94 China veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 95 China veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 96 Japan veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 97 Japan veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 98 Japan veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
Table 99 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 100 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 101 Japan veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 102 India veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 103 India veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 104 India veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 105 India veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 106 India veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 107 India veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 108 South Korea veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 109 South Korea veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 110 South Korea veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 111 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 112 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 113 South Korea veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 114 Australia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 115 Australia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 116 Australia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 117 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 118 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 119 Australia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 120 Thailand veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 121 Thailand veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 122 Thailand veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 123 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 124 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 125 Thailand veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 126 Latin America veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 127 Latin America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 128 Latin America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 129 Latin America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 130 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 131 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 132 Latin America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 133 Brazil veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 134 Brazil veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 135 Brazil veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 136 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 137 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 138 Brazil veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 139 Mexico veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 140 Mexico veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 141 Mexico veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 142 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 143 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 144 Mexico veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 145 Argentina veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 146 Argentina veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 147 Argentina veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 148 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 149 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 150 Argentina veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 151 MEA veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 152 MEA veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 153 MEA veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 154 MEA veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 155 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 156 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 157 MEA veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 158 South Africa veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 159 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 160 South Africa veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 161 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 162 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 163 South Africa veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 164 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 165 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 166 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 167 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 168 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 169 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018-2030 (USD Million)
Table 170 UAE veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 171 UAE veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 172 UAE veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
Table 173 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 174 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 175 UAE veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 176 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 177 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 178 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 179 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 180 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 181 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 182 Company Overview
Table 183 Product Benchmarking
Table 184 Financial Performance
Table 185 Strategic Initiatives
Table 2 Global veterinary active pharmaceutical ingredients manufacturing market, by region, 2018-2030 (USD Million)
Table 3 Global veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 4 Global veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 -2030 (USD Million)
Table 5 Global veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 6 Global veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 7 Global veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 8 Global veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 9 North America veterinary active pharmaceutical ingredients manufacturing market, by country, (USD Million) 2018-2030 (USD Million)
Table 10 North America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 11 North America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 12 North America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 13 North America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 14 North America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 15 North America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 16 U.S. veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 17 U.S. veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 18 U.S. veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 19 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 20 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 21 U.S. veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 22 Canada veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 23 Canada veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018-2030 (USD Million)
Table 24 Canada veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
Table 25 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, (USD Million) 2018-2030 (USD Million)
Table 26 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract development, (USD Million) 2018-2030 (USD Million)
Table 27 Canada veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018-2030 (USD Million)
Table 28 Europe veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 29 Europe veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 30 Europe veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 31 Europe veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 32 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 33 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 34 Europe veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 35 Germany veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 36 Germany veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 37 Germany veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 38 Germany veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 39 Germany veterinary active pharmaceutical ingredients manufacturing , by contract development, 2018-2030 (USD Million)
Table 40 Germany veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 41 UK veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 42 UK veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018- 2030 (USD Million)
Table 43 UK veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 44 UK veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 45 UK veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 46 UK veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 47 France veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 48 France veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 49 France veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 50 France veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 51 France veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 52 France veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 53 Italy veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 54 Italy veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 55 Italy veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 56 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 57 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 58 Italy veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 59 Spain veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 60 Spain veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 61 Spain veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 62 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 63 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 64 Spain veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 65 Denmark veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 66 Denmark veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 67 Denmark veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 68 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 69 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 70 Denmark veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 71 Sweden veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 72 Sweden veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 73 Sweden veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 74 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 75 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 76 Sweden veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 77 Norway veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 78 Norway veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 79 Norway veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 80 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 81 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 82 Norway veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 83 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 84 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 85 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 86 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 87 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 88 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 89 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 90 China veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 91 China veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 92 China veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 93 China veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 94 China veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 95 China veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 96 Japan veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 97 Japan veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 98 Japan veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
Table 99 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 100 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 101 Japan veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 102 India veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 103 India veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 104 India veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 105 India veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 106 India veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 107 India veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 108 South Korea veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 109 South Korea veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 110 South Korea veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 111 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 112 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 113 South Korea veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 114 Australia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 115 Australia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 116 Australia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 117 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 118 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 119 Australia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 120 Thailand veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 121 Thailand veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 122 Thailand veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 123 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 124 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 125 Thailand veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 126 Latin America veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 127 Latin America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 128 Latin America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 129 Latin America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 130 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 131 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 132 Latin America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 133 Brazil veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 134 Brazil veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 135 Brazil veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 136 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 137 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 138 Brazil veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 139 Mexico veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 140 Mexico veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 141 Mexico veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 142 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 143 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 144 Mexico veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 145 Argentina veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 146 Argentina veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 147 Argentina veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 148 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 149 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 150 Argentina veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 151 MEA veterinary active pharmaceutical ingredients manufacturing market, by country, 2018-2030 (USD Million)
Table 152 MEA veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 153 MEA veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 154 MEA veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 155 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 156 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 157 MEA veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 158 South Africa veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 159 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 160 South Africa veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 161 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 162 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 163 South Africa veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 164 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 165 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 166 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 167 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 168 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 169 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018-2030 (USD Million)
Table 170 UAE veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 171 UAE veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 172 UAE veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
Table 173 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 174 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 175 UAE veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 176 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018-2030 (USD Million)
Table 177 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018-2030 (USD Million)
Table 178 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
Table 179 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
Table 180 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
Table 181 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018-2030 (USD Million)
Table 182 Company Overview
Table 183 Product Benchmarking
Table 184 Financial Performance
Table 185 Strategic Initiatives
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Veterinary active pharmaceutical ingredients manufacturing market outlook
Fig. 10 Veterinary active pharmaceutical ingredients manufacturing market snapshot
Fig. 11 Veterinary active pharmaceutical Ingredients Manufacturing market driver impact
Fig. 12 Veterinary active pharmaceutical ingredients manufacturing market restraint impact
Fig. 13 Porter’s 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 Veterinary active pharmaceutical ingredients manufacturing market animal type key takeaways (USD Million)
Fig. 16 Veterinary active pharmaceutical ingredients manufacturing market: animal type movement & market share analysis, 2023 & 2030
Fig. 17 Global production animals market, 2018-2030 (USD Million)
Fig. 18 Global companion animals market, 2018-2030 (USD Million)
Fig. 19 Veterinary active pharmaceutical ingredients manufacturing market: Synthesis Type and key takeaways (USD Million)
Fig. 20 Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement & market share analysis, 2023 & 2030
Fig. 21 Global chemical based API market, 2018-2030 (USD Million)
Fig. 22 Global biological API market, 2018-2030 (USD Million)
Fig. 23 Global HPAPI market, 2018-2030 (USD Million)
Fig. 24 Veterinary active pharmaceutical ingredients manufacturing market: Service type & key takeaways (USD Million)
Fig. 25 Veterinary active pharmaceutical ingredients manufacturing market: Service type movement & market share analysis, 2023 & 2030
Fig. 26 Global in house market, 2018-2030 (USD Million)
Fig. 27 Global contract outsourcing market, 2018-2030 (USD Million)
Fig. 28 Global contract development market, 2018-2030 (USD Million)
Fig. 29 Global contract manufacturing market, 2018-2030 (USD Million)
Fig. 30 Global preclinical development market, 2018-2030 (USD Million)
Fig. 31 Global clinical development market, 2018-2030 (USD Million)
Fig. 32 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic category & key takeaways (USD Million)
Fig. 33 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic Category movement & market share analysis, 2023 & 2030
Fig. 34 Global antiparasitics market, 2018-2030 (USD Million)
Fig. 35 Global Anti-infectives market, 2018-2030 (USD Million)
Fig. 36 Global NSAIDs market, 2018-2030 (USD Million)
Fig. 37 Global Others market, 2018-2030 (USD Million)
Fig. 38 Regional market place: Key takeaways
Fig. 39 Regional outlook, 2023 & 2030
Fig. 40 North America veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 41 U.S. veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 42 Canada veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 43 Europe veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 44 UK veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 45 Germany veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 46 France veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 47 Italy veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 48 Spain veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 49 Denmark veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 50 Sweden veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 51 Norway veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 52 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 53 Japan veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 54 China veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 55 India veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 56 South Korea veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 57 Australia veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 58 Thailand veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 59 Latin America veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 60 Brazil veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 61 Mexico veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 62 Argentina veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 63 MEA veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 64 South Africa veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 65 UAE veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 66 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 67 Kuwait veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 68 Market participant categorization
Fig. 69 Heat map analysis
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Veterinary active pharmaceutical ingredients manufacturing market outlook
Fig. 10 Veterinary active pharmaceutical ingredients manufacturing market snapshot
Fig. 11 Veterinary active pharmaceutical Ingredients Manufacturing market driver impact
Fig. 12 Veterinary active pharmaceutical ingredients manufacturing market restraint impact
Fig. 13 Porter’s 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 Veterinary active pharmaceutical ingredients manufacturing market animal type key takeaways (USD Million)
Fig. 16 Veterinary active pharmaceutical ingredients manufacturing market: animal type movement & market share analysis, 2023 & 2030
Fig. 17 Global production animals market, 2018-2030 (USD Million)
Fig. 18 Global companion animals market, 2018-2030 (USD Million)
Fig. 19 Veterinary active pharmaceutical ingredients manufacturing market: Synthesis Type and key takeaways (USD Million)
Fig. 20 Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement & market share analysis, 2023 & 2030
Fig. 21 Global chemical based API market, 2018-2030 (USD Million)
Fig. 22 Global biological API market, 2018-2030 (USD Million)
Fig. 23 Global HPAPI market, 2018-2030 (USD Million)
Fig. 24 Veterinary active pharmaceutical ingredients manufacturing market: Service type & key takeaways (USD Million)
Fig. 25 Veterinary active pharmaceutical ingredients manufacturing market: Service type movement & market share analysis, 2023 & 2030
Fig. 26 Global in house market, 2018-2030 (USD Million)
Fig. 27 Global contract outsourcing market, 2018-2030 (USD Million)
Fig. 28 Global contract development market, 2018-2030 (USD Million)
Fig. 29 Global contract manufacturing market, 2018-2030 (USD Million)
Fig. 30 Global preclinical development market, 2018-2030 (USD Million)
Fig. 31 Global clinical development market, 2018-2030 (USD Million)
Fig. 32 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic category & key takeaways (USD Million)
Fig. 33 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic Category movement & market share analysis, 2023 & 2030
Fig. 34 Global antiparasitics market, 2018-2030 (USD Million)
Fig. 35 Global Anti-infectives market, 2018-2030 (USD Million)
Fig. 36 Global NSAIDs market, 2018-2030 (USD Million)
Fig. 37 Global Others market, 2018-2030 (USD Million)
Fig. 38 Regional market place: Key takeaways
Fig. 39 Regional outlook, 2023 & 2030
Fig. 40 North America veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 41 U.S. veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 42 Canada veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 43 Europe veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 44 UK veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 45 Germany veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 46 France veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 47 Italy veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 48 Spain veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 49 Denmark veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 50 Sweden veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 51 Norway veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 52 Asia-Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 53 Japan veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 54 China veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 55 India veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 56 South Korea veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 57 Australia veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 58 Thailand veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 59 Latin America veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 60 Brazil veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 61 Mexico veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 62 Argentina veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 63 MEA veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 64 South Africa veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 65 UAE veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 66 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 67 Kuwait veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (USD Million)
Fig. 68 Market participant categorization
Fig. 69 Heat map analysis
Companies Mentioned
- Zoetis
- Alivira Animal Health Limited
- Ofichem Group
- Chempro Pharma Private Limited
- Siflon Drugs
- Qilu Animal Health Products Co., Ltd.
- Vetpharma
- SUANFARMA
- MENADIONA
- Excel Industries Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | January 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 8.54 Billion |
| Forecasted Market Value ( USD | $ 13.47 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
